The development, announced by Novo Nordisk, may enhance pricing flexibility, support broader patient access, and strengthen the overall value proposition of Wegovy in European health technology assessments and reimbursement decisions
22, underscores an increasing demand for weight loss drugs across the U.S
Novo Nordisk, which makes Ozempic, Wegovy and similar drugs, said the firms clinical trial and post-marketing safety data did not show that the medications led to aspiration
This distinction matters enormously when considering whether rotation between them is safe, effective, or even practical
The most notable difference is that Victoza requires daily injections while Ozempic is administered as a once weekly injection